External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ACRC/Macula 2026

-
Coming soon
02:46 PM
Duration 6mins United States
Interim Analysis of the Belvedere nAMD Study: Summary of PDS Treatment in Eyes With High Injection Burden
Michael A. Klufas, Steven Blotner, Brianne Chin, Andrew Gordon, Shamika Gune

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar